pharma · Idiopathic Pulmonary Fibrosis · Idiopathic pulmonary fibrosis (IPF) · PLRX
PLIANT THERAPEUTICS
PLIANT THERAPEUTICS, INC.
PLIANT THERAPEUTICS patent portfolio — 13 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- South San Francisco, USA
- Founded
- 2015
- Employees
- 122
- Programs
- 6
- Drugs
- 3
- Patents
- 13
PLIANT THERAPEUTICS patents
13 pharmaceutical patents indexed for PLIANT THERAPEUTICS. 0 expire within 24 months.
PLIANT THERAPEUTICS has 13 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12390463
Dosage forms and regimens for amino acid compounds
granted -
US 12134642
Antibodies binding to α7β1 integrin antibodies and compositions thereof
granted -
US 11952376
Substituted amino acids as integrin inhibitors
granted -
US 11858931
Amino acid compounds with unbranched linkers and methods of use
granted -
US 11673887
N-acyl amino acid compounds and methods of use
granted -
US 11634418
Amino acid compounds and methods of use
granted -
US 11560376
Amino acid compounds and methods of use
granted -
US 11419869
Dosage forms and regimens for amino acid compounds
granted -
US 11396506
Amino acid compounds with unbranched linkers and methods of use
granted -
US 11180494
Substituted amino acids as integrin inhibitors
granted -
US 10793564
Amino acid compounds and methods of use
granted -
US 10696672
Amino acid compounds and methods of use
granted -
US 10604520
N-acyl amino acid compounds and methods of use
granted
Frequently asked questions
How many patents does PLIANT THERAPEUTICS have?
13 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do PLIANT THERAPEUTICS patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.